Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Current Leases (2019 - 2025)

Historic Current Leases for Northwest Biotherapeutics (NWBO) over the last 7 years, with Q3 2025 value amounting to $399000.0.

  • Northwest Biotherapeutics' Current Leases rose 5585.94% to $399000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $399000.0, marking a year-over-year increase of 5585.94%. This contributed to the annual value of $326000.0 for FY2024, which is 382.17% up from last year.
  • Northwest Biotherapeutics' Current Leases amounted to $399000.0 in Q3 2025, which was up 5585.94% from $448000.0 recorded in Q2 2025.
  • Northwest Biotherapeutics' Current Leases' 5-year high stood at $448000.0 during Q2 2025, with a 5-year trough of $170000.0 in Q1 2021.
  • In the last 5 years, Northwest Biotherapeutics' Current Leases had a median value of $326000.0 in 2024 and averaged $318894.7.
  • Its Current Leases has fluctuated over the past 5 years, first crashed by 5572.92% in 2021, then surged by 15600.0% in 2025.
  • Over the past 5 years, Northwest Biotherapeutics' Current Leases (Quarter) stood at $317000.0 in 2021, then increased by 11.67% to $354000.0 in 2022, then fell by 11.3% to $314000.0 in 2023, then increased by 3.82% to $326000.0 in 2024, then rose by 22.39% to $399000.0 in 2025.
  • Its last three reported values are $399000.0 in Q3 2025, $448000.0 for Q2 2025, and $390000.0 during Q1 2025.